News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Allies in Paris seek expanded air-defence and munitions commitments for Ukraine and coordination on sanctions and oil curbs.
  • HHS OIG reports $5.56 billion in expected recoveries and exclusions while criminal and civil enforcement actions hit a two-year low.
  • Ryohin Keikaku raised full-year revenue and profit forecasts, sending Muji operator's Tokyo-listed shares to a record high.
  • Mastercard is exploring selling a majority stake in UK payments platform Vocalink, with talks at an early stage and no offers.
  • A 51% Vocalink sale could be valued near 400 million pounds amid UK moves to boost retail payments competition, but any deal may wait.

Latest Articles

Luxfer Holdings Director Snowdon Sells $60,425 in LXFR Stock

Luxfer Holdings Director Snowdon Sells $60,425 in LXFR Stock

Luxfer Holdings PLC director Clive Snowdon executed indirect transactions involving the company's ordinary shares and Restricted Stock Units on June 11, 2026. The filings detail a partial sale of equity holdings alongside the vesting of new awards and the granting of additional non-discretionary units. These moves occur as Luxfer posts a strong sta…

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Nano Dimension Ltd. (Nasdaq: NNDM) announced a non-binding term sheet to combine with Infinite Epigenetics, an AI-powered preventive health and diagnostics company. The transaction will leverage Nano Dimension's Nasdaq listing and capital to accelerate growth in the healthcare AI sector. Infinite Epigenetics focuses on epigenetic diagnostics target…

Anfield Energy Announces a Key Milestone in Equipment Procurement, Advancing the Company Towards Hub-and-Spoke Production

Anfield Energy Announces a Key Milestone in Equipment Procurement, Advancing the Company Towards Hub-and-Spoke Production

Anfield Energy Inc. received the first custom-built underground haul truck from Young’s Machine Company, marking a key milestone in its equipment procurement program. This delivery supports the company’s uranium-vanadium mining operations in Utah and Colorado, advancing production under its hub-and-spoke model. Additionally, Anfield secured a new a…

Doncasters Files for U.S. IPO, Seeking Up to $747 Million

Doncasters Files for U.S. IPO, Seeking Up to $747 Million

DPC Holdings Limited, trading as Doncasters, filed for an initial public offering in the United States to raise up to $747 million by selling 33,333,333 shares on the New York Stock Exchange. The proposed price range is $28 to $32 per share, which would value the company at more than $3.7 billion at the high end. The aerospace components maker repo…

World Cup Sparks Record Daily Trading in Prediction Markets

World Cup Sparks Record Daily Trading in Prediction Markets

Prediction market trading surged to a record $4.8 billion in daily volume on June 12 as the World Cup group stages got under way, after opening-day activity of $2.2 billion on June 11. The jump in volume followed the United States match against Paraguay and already surpasses last season's Super Bowl total of $1.4 billion. Polymarket's U.S. platform…

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Dyadic International highlights growing interest in its proprietary C1 protein production platform driven by intensified Ebola virus outbreak preparedness and expanding commercial adoption across multiple markets. The platform's rapid development capabilities support expedited vaccine antigen and monoclonal antibody production, aligning with global…

Moscow Denounces Claims Its Forces Hit Kyiv’s Pechersk Lavra as a 'Crude Fake'

Moscow Denounces Claims Its Forces Hit Kyiv’s Pechersk Lavra as a 'Crude Fake'

Russian authorities on June 15 dismissed accusations from Kyiv and Western governments that Russian forces struck the 1,000-year-old Pechersk Lavra monastery in Kyiv. Moscow's Defence Ministry denied targeting the site and suggested a U.S.-made Patriot air defence missile was responsible, while the Foreign Ministry called the allegations a "crude f…

Retail Investors Face Stricter Flipping Limits Than Funds in SpaceX IPO

Retail Investors Face Stricter Flipping Limits Than Funds in SpaceX IPO

Retail participants in the SpaceX initial public offering confronted steeper restrictions on so-called flipping than large institutional buyers. Broker platforms set 15- to 30-day hold windows and punishments ranging from temporary suspensions to permanent bans for accounts that sell too soon, while some large asset managers and hedge funds have lo…

Shippers Say Safe Conditions Must Come First Before Hormuz Traffic Resumes

Shippers Say Safe Conditions Must Come First Before Hormuz Traffic Resumes

Shipping firms in Asia and Europe welcomed a U.S.-Iran framework to reopen the Strait of Hormuz but say confidence will take weeks to rebuild. Industry groups and carriers want clear evidence of safety, including mine clearance and normalized insurance, before vessels return to regular routing. Limited transit was visible on Monday, while global oi…

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

Elicio Therapeutics announced that its Phase 2 AMPLIFY-7P study of ELI-002 7P immunotherapy in adjuvant mKRAS-driven pancreatic cancer did not meet the primary disease-free survival endpoint in the intent-to-treat population. However, post-hoc analyses revealed a significant benefit in patients with R0 resection, who represent the majority of the s…

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Seer, Inc.'s Board of Directors has issued a letter to shareholders ahead of the July 28, 2026 Annual Meeting, urging a vote in favor of the current board slate amid activist investor attempts to replace directors and push for a sale. The letter highlights Seer's pioneering leadership in proteomics technology, ongoing large-scale scientific studies…